An attempt to patent a medicine already patented in the U.S. and elsewhere, and currently being developed by U.S. drugmaker Gilead Sciences, raises serious intellectual

An attempt to patent a medicine already patented in the U.S. and elsewhere, and currently being developed by U.S. drugmaker Gilead Sciences, raises serious intellectual